Efficacy of over-the-counter nicotine patch

Nicotine and Tobacco Research

Volumn 4, Issue 4, 2002, Pages 477-483

  Shiffman, Saul ^a   Gorsline, Jane ^b   Gorodetzky, Charles W ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b ALZA CORPORATION   (United States)

^c IQVIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINE; NON PRESCRIPTION DRUG; PLACEBO;

ADULT; ARTICLE; BEHAVIOR THERAPY; CIGARETTE SMOKING; CLINICAL OBSERVATION; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; INSOMNIA; MALE; MEDICAL ASSESSMENT; MULTICENTER STUDY; MYALGIA; NAUSEA; PATIENT COUNSELING; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; SIMULATION; SKIN MANIFESTATION; SMOKING CESSATION; TREATMENT FAILURE; TREATMENT OUTCOME; UNPLEASANT DREAM; XEROSTOMIA;

ADMINISTRATION, TOPICAL; ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; SMOKING; SMOKING CESSATION;

EID: 0036867448     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/1462220021000018416     Document Type: Article

References (23)

1. Burton S. L., Gitchell J. G., Shiffman S. (1998). Use of FDA-approved pharmacologic treatments for tobacco dependence - United States, 1984-1998. Morbidity and Mortality Weekly Report 49, 665-668.
2. Centers for Disease Control and Prevention (CDC). (1999). Achievements in public health, 1900-1999: tobacco use - United States, 1900-1999. Morbidity and Mortality Weekly Report 48, 986-993.
3. Cepeda-Benito A. (1993). Meta-analytic review of the efficacy of nicotine chewing gum in smoking treatment programs. Journal of Consulting and Clinical Psychology 61, 822-830.
4. Curry S. J., Grothaus L. C., McAfee T., Pabiniak C. (1998). Use and cost effectiveness of smoking cessation services under four insurance plans in a health maintenance organization. New England Journal of Medicine 339, 673-679.
5. Davidson M., Epstein M., Burt R., Schaefer C., Whitworth G., McDonald A. (1998). Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Archives of Family Medicine 7, 569-574.
6. Fiore M. C., Bailey W. C., Cohen S. J., et al. (2000). Treating tobacco use and dependence. Clinical practice guideline. Rockville, MD: USDHHS, Public Health Service.
7. Hays J. T., Croghan I. T., Schroeder D. R., Offord K. R, Hurt R. D., Wolter T. D., Nides M. A., Davidson M. (1999). Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. American Journal of Public Health 89, 1701-1707.
8. Hughes J. R. (1995). Combining behavioral therapy and pharmacotherapy for smoking cessation: an update. In L. S. Onken, J. D. Blaine, J. J. Boren, (Eds.). Integrating behavior therapies with medication in the treatment of drug dependence. NIDA Research Monograph. (pp. 92-109). Washington, DC: U.S. Government Printing Office
9. Hughes J. R., Gulliver S. B., Amori G., Mireault G. C., Fenwick J. F. (1989). Effect of instructions and nicotine on smoking cessation, withdrawal symptoms and self-administration of nicotine gum. Psychopharmacology 99, 486-491.
10. Hughes J. R., Gulliver S. B., Fenwick J. W., Valliere W. A., Cruser K., Pepper S., Shea P., Solomon L. J., Flynn B. S. (1992). Smoking cessation among self-quitters. Health Psychology 11, 331-334.
11. Jolicoeur D. G., Ahluwalia J. S., Richter K. P., Mosier M., Harris K. J., Gibson C., Moranetz C. A. (2000). The use of nicotine patches with minimal intervention. Preventive Medicine 30, 504-512.
12. Lancaster T., Stead L., Silagy C., Sowden A.. Cochrane Tobacco Addiction Review Group. (2000). Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. British Medical Journal 321, 355-358.
13. Leischow S. J., Muramoto M. L., Cook G. N., Merikle E. P., Castellini S. M., Otte P. S. (1999). OTC nicotine patch: effectiveness alone and with brief physician intervention. American Journal of Health Behavior 23, 61-69.
14. Shiffman S., Paty J. A., Rohay J. M., Di Marino M. E., Gitchell J. G. (2000). The efficacy of computer-tailored smoking cessation material as a supplement to nicotine polacrilex gum therapy. Archives of Internal Medicine 160, 1675-1681.
15. Shiffman S., Paty J. A., Rohay J. M., Di Marino M. E., Gitchell J. G. (2001). The efficacy of computer-tailored smoking cessation material as a supplement to nicotine patch therapy. Drug and Alcohol Dependence, 64, 35-46.
16. Shiffman S., Gitchell J. G., Pinney J. M., Burton S. L., Kemper K. E., Lara E. A. (1997). Public health impact of over-the-counter nicotine medications. Tobacco Control 6, 306-310.
17. Silagy C., Mant D., Fowler G., Lancaster T. (2000). Nicotine replacement therapy for smoking cessation. The Cochrane Library.
18. SmithKline Beecham Consumer Healthcare. (2002). [Information about NicoDerm CQ patch purchasers.] Unpublished data.
19. Sonderskov J., Olsen J., Sabroe S., Meillier L., Overvad K. (1997). Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. American Journal of Epidemiology 145, 309-318.
20. Transdermal Nicotine Study Group. (1991). Transdermal nicotine for smoking cessation. Journal of the American Medical Association 266, 3133-3138.
21. US Food and Drug Administration (US FDA). (1995), September 28. Transcript of the Joint Meeting of the Nonprescription Drugs Advisory Committee and the Drug Abuse Advisory Committee of the Food and Drug Administration. Rockville, MD.
22. Walsh R. A., Penman A. G. (2000). The effectiveness of nicotine replacement therapy over-the-counter. Drug and Alcohol Review 19, 43-247.
23. Winchell C. J., Wright C., Burke L., Kramer E. D., Longmire A. W., Scheinbaum M. L. (1997). Long-term abstinence in users of OTC nicotine replacement. Clinical Pharmacology and Therapeutics 61, 191.